Cargando…

Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis

BACKGROUND: The Global Programme to Eliminate Lymphatic Filariasis (LF) emphasizes hygiene, exercise, and other measures to reduce morbidity and disability related to LF. We recently reported that a portable, three-dimensional, infrared imaging system (3DIS) provides accurate limb volume measurement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Celia, Yahathugoda, Channa, De Silva, Lalindi, Rathnapala, Upeksha, Owen, Grant, Weerasooriya, Mirani, Rao, Ramakrishna U., Weil, Gary J., Budge, Philip J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795459/ https://www.ncbi.nlm.nih.gov/pubmed/31584959 http://dx.doi.org/10.1371/journal.pntd.0007762

Ejemplares similares

Validation of an In-House ELISA Method in the Diagnosis of Cutaneous Leishmaniasis Caused by Leishmania donovani in Hambantota District, Sri Lanka
por: De Silva, Nirmitha Lalindi, et al.
Publicado: (2022)

Development of a Highly Sensitive Nested PCR and Its Application for the Diagnosis of Cutaneous Leishmaniasis in Sri Lanka
por: De Silva, Nirmitha Lalindi, et al.
Publicado: (2022)

Surveillance of Wuchereria bancrofti infection by anti-filarial IgG4 in urine among schoolchildren and molecular xenomonitoring in Sri Lanka: a post mass drug administration study
por: Takagi, Hidekazu, et al.
Publicado: (2019)

Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
por: Weerasooriya, Mirani V, et al.
Publicado: (2007)

A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration
por: Yahathugoda, Thishan C., et al.
Publicado: (2015)

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
por: Horton, John, et al.
Publicado: (2020)

Neglected Patients with a Neglected Disease? A Qualitative Study of Lymphatic Filariasis
por: Perera, Myrtle, et al.
Publicado: (2007)

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature
por: Budge, Philip J., et al.
Publicado: (2018)

Multicentre evaluations of two new rapid IgG4 tests (WB rapid and panLF rapid) for detection of lymphatic filariasis
por: Noordin, Rahmah, et al.
Publicado: (2007)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis
por: Hertz, Marla I., et al.
Publicado: (2018)

Geospatial modelling of lymphatic filariasis and malaria co-endemicity in Nigeria
por: Eneanya, Obiora A, et al.
Publicado: (2023)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Lymphatic Filariasis: A Method to Identify Subclinical Lower Limb Change in PNG Adolescents
por: Gordon, Susan, et al.
Publicado: (2011)

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2017)

Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo
por: Chesnais, Cédric B., et al.
Publicado: (2019)

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d’Ivoire: A randomized controlled superiority study
por: Bjerum, Catherine M., et al.
Publicado: (2023)

Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2019)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Lymphatic Filariasis Disseminating to the Upper Extremity
por: Maldjian, Catherine, et al.
Publicado: (2014)

The burden of mental health in lymphatic filariasis
por: Ton, Thanh G.N., et al.
Publicado: (2015)

Environmental suitability for lymphatic filariasis in Nigeria
por: Eneanya, Obiora A., et al.
Publicado: (2018)

Review of Dancing Parasites in Lymphatic Filariasis
por: Dietrich, Christoph F., et al.
Publicado: (2019)

Lymphatic filariasis presenting as retroperitoneal cyst
por: Sancheti, Prachi M., et al.
Publicado: (2020)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

A case study of risk factors for lymphatic filariasis in the Republic of Congo
por: Chesnais, Cédric B, et al.
Publicado: (2014)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
por: Ranganath, TS, et al.
Publicado: (2012)

Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka
por: Rao, Ramakrishna U., et al.
Publicado: (2016)

A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration
por: Rao, Ramakrishna U., et al.
Publicado: (2014)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis
por: Budge, Philip J., et al.
Publicado: (2016)

How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis
por: Kastner, Randee J., et al.
Publicado: (2017)

A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery
por: Weil, Gary J, et al.
Publicado: (2020)

A Randomized Trial of a New Triple Drug Treatment for Lymphatic Filariasis
por: King, Christopher L., et al.
Publicado: (2018)

The geographical distribution of lymphatic filariasis infection in Malawi
por: Ngwira, Bagrey MM, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_mjeded1gv2u44gtds4umbvnol5